Fundamental Analysis of Conformis Inc(NASDAQ:CFMS) stock

Fundamental Rating

CFMS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. CFMS may be in some trouble as it scores bad on both profitability and health. CFMS has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

CFMS had negative earnings in the past year.

CFMS had a negative operating cash flow in the past year.

CFMS had negative earnings in each of the past 5 years.

In the past 5 years CFMS always reported negative operating cash flow.

1.2 Ratios

The profitability ratios for CFMS are negative, so there is not much use analyzing them.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CFMS has a Gross Margin of 33.21%. This is in the lower half of the industry: CFMS underperforms 70.85% of its industry peers.

In the last couple of years the Gross Margin of CFMS has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for CFMS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	33.21%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-7.62%

GM growth 5Y0.29%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CFMS does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, CFMS has more shares outstanding

CFMS has less shares outstanding than it did 5 years ago.

Compared to 1 year ago, CFMS has a worse debt to assets ratio.

2.2 Solvency

CFMS has an Altman-Z score of -12.53. This is a bad value and indicates that CFMS is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -12.53, CFMS is doing worse than 85.93% of the companies in the same industry.

CFMS has a Debt/Equity ratio of 0.64. This is a neutral value indicating CFMS is somewhat dependend on debt financing.

CFMS has a Debt to Equity ratio of 0.64. This is in the lower half of the industry: CFMS underperforms 70.85% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.64
Debt/FCF	N/A
Altman-Z	-12.53

ROIC/WACCN/A

WACC10.06%

2.3 Liquidity

CFMS has a Current Ratio of 5.07. This indicates that CFMS is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 5.07, CFMS is in the better half of the industry, outperforming 64.32% of the companies in the same industry.

A Quick Ratio of 3.30 indicates that CFMS has no problem at all paying its short term obligations.

CFMS has a Quick ratio of 3.30. This is comparable to the rest of the industry: CFMS outperforms 58.29% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.07
Quick Ratio	3.3

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CFMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.00%, which is quite impressive.

The Revenue has decreased by -5.72% in the past year.

Measured over the past years, CFMS shows a decrease in Revenue. The Revenue has been decreasing by -4.50% on average per year.

EPS 1Y (TTM)34%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q20.89%

Revenue 1Y (TTM)-5.72%

Revenue growth 3Y-7.12%

Revenue growth 5Y-4.5%

Revenue growth Q2Q-14.85%

3.2 Future

The Earnings Per Share is expected to grow by 15.18% on average over the next years. This is quite good.

CFMS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.56% yearly.

EPS Next Y24.27%

EPS Next 2Y15.18%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-8.57%

Revenue Next 2Y0.56%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CFMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year CFMS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

CFMS's earnings are expected to grow with 15.18% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y15.18%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CFMS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

Conformis Inc

NASDAQ:CFMS (9/1/2023, 7:00:15 PM)

After market: 2.26 0 (0%)

2.26

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap17.80M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	33.21%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.84

Health

		Industry Rank	Sector Rank
Debt/Equity	0.64
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	5.07
Quick Ratio	3.3
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)34%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y24.27%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-5.72%

Revenue growth 3Y-7.12%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

Conformis Inc (CFMS)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens